Hepatocellular cancer (HCC) patients on phase I clinical trials in sorafenib era: Analysis of a single institution experience in last 10 years.
Vinu Madhusudanannair
No relevant relationships to disclose
Brad H. Pollock
No relevant relationships to disclose
Norma Ketchum
No relevant relationships to disclose
Steven D. Weitman
No relevant relationships to disclose
John Sarantopoulos
No relevant relationships to disclose
Devalingam Mahalingam
No relevant relationships to disclose